Flash BioSolutions appoints Anne DEFLISQUE Business & Marketing Director to boost growth


We are thrilled to announce the newest addition to our leadership team at Flash BioSolutions! Join us in welcoming Anne DEFLISQUE as our Business and Marketing Director, effective April 10, 2024.

Toulouse, France, 10 April 2024 - Flash BioSolutions proudly announces the appointment of Anne DEFLISQUE as its Business and Marketing Director, effective April 10, 2024. This strategic addition to the team underscores Flash BioSolutions' commitment to bolstering its leadership and propelling its growth initiatives within the dynamic field of cell and gene therapy.


Anne DEFLISQUE, based in Toulouse, Occitanie, France, brings a wealth of experience to her new role, having previously served as the Sales and Marketing Director at Vaiomer. Her professional journey includes notable positions at MilleGen, and in bio-process divisions of GE Healthcare and Pharmacia Biotech (Cytiva). With a diverse background spanning various facets of the industry, Anne holds an Engineering degree in Biotechnologies (PBA) from UTC (Université de Technologie de Compiègne - France).

Anne's extensive skill set encompasses Development, International Business, Technology, Key Account Management, Open Innovation, and more, positioning her as a valuable asset to Flash BioSolutions. In her new capacity, she will lead the company's commercialization strategy, with a focus on identifying new opportunities for growth and nurturing relationships with clients and partners. Anne's leadership and innovative mindset will play a pivotal role in consolidating Flash BioSolutions' position as the leading CDMO in DNA and RNA gene delivery.

Anne DEFLISQUE's appointment aligns strategically with Flash BioSolutions' expansion efforts, as the company remains dedicated to delivering cutting-edge biotechnology solutions to its global clientele.


"We are delighted to welcome Anne DEFLISQUE to the leadership team at Flash BioSolutions. Her wealth of experience and expertise will be instrumental in driving our strategic objectives forward," commented Jérôme Bédier, CEO of Flash BioSolutions. "Her appointment underscores our unwavering commitment to excellence and our determination to innovate and thrive in an ever-evolving business landscape."

Anne DEFLISQUE expressed "I am thrilled to join Flash BioSolutions at such an exciting time in the company's growth trajectory. I look forward to leveraging my experience and skills to drive forward our commercialization strategy and foster impactful collaborations with our clients and partners. I am deeply committed to advancing Flash BioSolutions' mission of delivering innovative biotechnology solutions to address the evolving needs of the gene and cell therapy field. Together, we will continue to push the boundaries of excellence and drive positive outcomes for patients worldwide."


About Flash BioSolutions :

Flash BioSolutions® is a preeminent CDMO specializing in the industrial-scale production of DNA and RNA vectors for clientele within the domains of gene and cell therapy, and vaccine development. Bolstered by a robust manufacturing platform and validated processes honed over two decades, Flash BioSolutions® excels in delivering vectors of unmatched purity and concentration across research, pre-clinical, clinical, and commercial phases.


Contact :

Head of communication
Soraya Sandokchi
+33 582 955 546


Fichier pdf Download the Press Release